{
    "paper_id": "PMC7144842",
    "metadata": {
        "title": "Novel decoy cellular vaccine strategy utilizing transgenic antigen-expressing cells as immune presenter and adjuvant in vaccine prototype against SARS-CoV-2 virus",
        "authors": [
            {
                "first": "Henry",
                "middle": [],
                "last": "Ji",
                "suffix": "",
                "email": "hji@sorrentotherapeutics.com",
                "affiliation": {}
            },
            {
                "first": "Ying",
                "middle": [],
                "last": "Yan",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Beibei",
                "middle": [],
                "last": "Ding",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Wenzhong",
                "middle": [],
                "last": "Guo",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Mark",
                "middle": [],
                "last": "Brunswick",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Andreas",
                "middle": [],
                "last": "Niethammer",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Williams",
                "middle": [],
                "last": "SooHoo",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Robin",
                "middle": [],
                "last": "Smith",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Alexis",
                "middle": [],
                "last": "Nahama",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Yanliang",
                "middle": [],
                "last": "Zhang",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "\nSorrento Therapeutics is funding the discovery, development and clinical supply manufacturing of the vaccine platform mentioned in this communication.",
            "cite_spans": [],
            "section": "Funding source",
            "ref_spans": []
        },
        {
            "text": "\nHenry Ji: Conceptualization. Ying Yan: Conceptualization. Beibei Ding: Conceptualization. Wenzhong Guo: Conceptualization. Mark Brunswick: Writing - review & editing. Andreas Niethammer: Original writing. Williams SooHoo: Visualization. Robin Smith: Writing - review & editing. Alexis Nahama: Writing - review & editing. Yanliang Zhang: Conceptualization.",
            "cite_spans": [],
            "section": "CRediT authorship contribution statement",
            "ref_spans": []
        },
        {
            "text": "The authors are employed (or Directors) of Sorrento Therapeutics, Inc. The current discovery strategy is being implemented for vaccine development under the I-Cell\u2122 label and within Sorrento's cGMP manufacturing facilities.",
            "cite_spans": [],
            "section": "Declaration of competing interest",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "FIGREF0": {
            "text": "Fig. 1: Targeted expression of SARS-CoV-2 Spike immunogen and resulting I-cell vaccine candidate.",
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Fig. 2: Elicitation of humoral and cellular immune responses following virus decoy cell vaccination.",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia",
            "authors": [
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Klein",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Ben-Bassat",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Neumann",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Ralph",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Zeuthen",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Polliack",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Int J Cancer",
            "volume": "18",
            "issn": "4",
            "pages": "421-431",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "Protection against natural killer cells by interferon-gamma treatment of K562 cells cannot be explained by augmented major histocompatibility complex class I expression",
            "authors": [
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Nishimura",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Mitsunaga",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Akaza",
                    "suffix": ""
                },
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Mitomi",
                    "suffix": ""
                },
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Tadokoro",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Juji",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "Immunology",
            "volume": "83",
            "issn": "1",
            "pages": "75-80",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "The role of Th17 and Treg responses in the pathogenesis of RSV infection",
            "authors": [
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Mangodt",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Van Herck",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Nullens",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Pediatr Res",
            "volume": "78",
            "issn": "",
            "pages": "483-491",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "Correction: immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus",
            "authors": [
                {
                    "first": "C.-T.",
                    "middle": [],
                    "last": "Tseng",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Sbrana",
                    "suffix": ""
                },
                {
                    "first": "N.",
                    "middle": [],
                    "last": "Iwata-Yoshikawa",
                    "suffix": ""
                },
                {
                    "first": "P.C.",
                    "middle": [],
                    "last": "Newman",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Garron",
                    "suffix": ""
                },
                {
                    "first": "R.L.",
                    "middle": [],
                    "last": "Atmar",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "PLoS ONE",
            "volume": "7",
            "issn": "8",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "Cancer therapy trial. Vaccination with lethally irradiated glioma cells mixed with GM-K562 cells in patients undergoing craniotomy for recurrent tumor",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Curry",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        }
    }
}